Boston Scientific accounts are for healthcare professionals only.
Improving the gold standard for laser lithotripsy
Its groundbreaking, patent-protected pulse delivery technology is designed to improve energy transmission, resulting in more efficient lithotripsy treatments compared to the standard holmium pulse.2
Physician-driven, patient-centered innovation
Whether you need more information about our benign prostatic hyperplasia or other urology products, access to education programs, or have a question about reimbursement, we can help.
*Compared with standard holmium pulse.
**Bench test results may not necessarily be indicative of clinical performance.
***MOSES optimization for high freq @ 120Hz: % increase = 100 X (1.176-0.611)/(0.611) = 92% 1.176 is a 92% increase of 0.611
+ Boston Scientific calculations for improvement in total operative time respectively: 85.9 vs 98.1 min, p=0.03.
References:
- Elhilali MM, Badaan S, Ibrahim A, Andonian S. Use of the Moses technology to improve holmium laser lithotripsy outcomes: A preclinical study. J Endourol. 2017;31:598–604.
- Ibrahim A, Elhilali MM, Fahmy N, Carrier S, Andonian S. Double-blinded prospective randomized clinical trial comparing regular and Moses modes of holmium laser lithotripsy. J Endourol. 2020;34:624–628.
- Dunne M, Drescher M, Abbott J, Davalos J. Lumenis Pulse MOSES Technology improves efficiency of laser lithotripsy for patients undergoing mini-PCNL. J Urol. 2021;206:e318.
Rx Only
All images are the property of Boston Scientific. All trademarks are the property of their respective owners.